tiprankstipranks
Advertisement
Advertisement

ZYME Stock Latest News

Zymeworks reports results from dose-escalation part of Phase 1 study for ZW191
The FlyZymeworks reports results from dose-escalation part of Phase 1 study for ZW191
3d ago
ZYME
Zymeworks Sets May 7 Date to Unveil Q1 2026 Results and Pipeline Update
PremiumCompany Announcements
Zymeworks Sets May 7 Date to Unveil Q1 2026 Results and Pipeline Update
8d ago
ZYME
Zymeworks Bolsters Executive Team to Drive Next Phase of Growth
PremiumCompany Announcements
Zymeworks Bolsters Executive Team to Drive Next Phase of Growth
15d ago
ZYME
Zymeworks appoints new Head of R&D and Chief Business Officer
PremiumThe Fly
Zymeworks appoints new Head of R&D and Chief Business Officer
15d ago
ZYME
Leerink says Tubulis deal highlights value of ADC platforms like Sutro’s
PremiumThe Fly
Leerink says Tubulis deal highlights value of ADC platforms like Sutro’s
17d ago
GILD
IMNM
Zymeworks Names Kristin Stafford as New Chief Financial Officer
PremiumCompany AnnouncementsZymeworks Names Kristin Stafford as New Chief Financial Officer
23d ago
ZYME
Zymeworks appoints Kristin Stafford as CFO
Premium
The Fly
Zymeworks appoints Kristin Stafford as CFO
23d ago
NVCR
ZYME
Zymeworks (ZYME): Advancing ADC Platform, Fast-Track ZW191, and Broad FRα Opportunity Support Buy Rating
Premium
Ratings
Zymeworks (ZYME): Advancing ADC Platform, Fast-Track ZW191, and Broad FRα Opportunity Support Buy Rating
25d ago
ZYME
Zymeworks Wins FDA Fast Track Status for Ovarian Cancer Drug ZW191
PremiumCompany Announcements
Zymeworks Wins FDA Fast Track Status for Ovarian Cancer Drug ZW191
25d ago
ZYME
Zymeworks receives FDA Fast Track Designation for ZW191
PremiumThe Fly
Zymeworks receives FDA Fast Track Designation for ZW191
25d ago
ZYME
Zymeworks announces Fast Track designation for ZW191 by FDA
PremiumThe Fly
Zymeworks announces Fast Track designation for ZW191 by FDA
25d ago
ZYME
Zymeworks to Highlight Pipeline and Asset Strategy at Key Investor Conferences
PremiumCompany Announcements
Zymeworks to Highlight Pipeline and Asset Strategy at Key Investor Conferences
1M ago
ZYME
Zymeworks Highlights New Ziihera Data to Broaden HER2 Cancer Reach
PremiumCompany AnnouncementsZymeworks Highlights New Ziihera Data to Broaden HER2 Cancer Reach
1M ago
ZYME
Zymework’ partner Jazz to present on Ziihera at 2026 AACR Annual Meeting
Premium
The Fly
Zymework’ partner Jazz to present on Ziihera at 2026 AACR Annual Meeting
1M ago
JAZZ
ZYME
Zymeworks Highlights ADC and Novel Pan-RAS Platform Data Ahead of AACR Meeting
Premium
Company Announcements
Zymeworks Highlights ADC and Novel Pan-RAS Platform Data Ahead of AACR Meeting
1M ago
ZYME
Zymeworks price target raised to $48 from $33 at Evercore ISI
PremiumThe Fly
Zymeworks price target raised to $48 from $33 at Evercore ISI
2M ago
RPRX
ZYME
Zymeworks Earnings Call: Zanidatumab Drives Bullish Outlook
PremiumCompany Announcements
Zymeworks Earnings Call: Zanidatumab Drives Bullish Outlook
2M ago
ZYME
Zymeworks price target raised to $46 from $32 at H.C. Wainwright
PremiumThe Fly
Zymeworks price target raised to $46 from $32 at H.C. Wainwright
2M ago
ZYME
Zymeworks: Strengthened Liquidity and Preserved Zanidatamab Royalty Upside Support Overweight Rating
PremiumRatings
Zymeworks: Strengthened Liquidity and Preserved Zanidatamab Royalty Upside Support Overweight Rating
2M ago
ZYME
Zymeworks price target raised to $47 from $40 at Stifel
PremiumThe FlyZymeworks price target raised to $47 from $40 at Stifel
2M ago
ZYME
Zymeworks’ Growth Clouded by High Clinical Failure Risk and Regulatory Uncertainty
Premium
Company Announcements
Zymeworks’ Growth Clouded by High Clinical Failure Risk and Regulatory Uncertainty
2M ago
ZYME
Morning Movers: Travel stocks fall following U.S.-Israeli strikes on Iran
Premium
The Fly
Morning Movers: Travel stocks fall following U.S.-Israeli strikes on Iran
2M ago
AAL
COP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >